AlphaCrest Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-134,969
Closed -$1.68M 359
2022
Q3
$1.68M Buy
134,969
+3,303
+3% +$57.7K 0.1% 295
2022
Q2
$2.58M Buy
131,666
+52,321
+66% +$1.24M 0.12% 205
2022
Q1
$2.07M Buy
79,345
+6,145
+8% +$164K 0.12% 232
2021
Q4
$2.08M Buy
73,200
+49,955
+215% +$1.55M 0.08% 409
2021
Q3
$741K Buy
23,245
+11,950
+106% +$401K 0.04% 750
2021
Q2
$392K Sell
11,295
-27,905
-71% -$920K 0.02% 1034
2021
Q1
$1.15M Buy
39,200
+21,300
+119% +$655K 0.06% 437
2020
Q4
$549K Buy
17,900
+8,400
+88% +$256K 0.05% 596
2020
Q3
$265K Buy
+9,500
New +$241K 0.03% 925
2020
Q2
Sell
-11,700
Closed -$262K 959
2020
Q1
$262K Buy
+11,700
New +$320K 0.03% 843

Other funds holding ELAN

AlphaCrest Capital Management's ELAN Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Elanco Animal Health (ELAN) in Q4 2022, closing a stake of 134,969 shares — an estimated $1.68M sold.

AlphaCrest Capital Management first reported a position in ELAN in Q1 2020 and held it in 10 quarters. The position peaked at $2.58M in Q2 2022. 404 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Elanco Animal Health position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 134,969 Elanco Animal Health shares in Q4 2022, an estimated $1.68M.
  • AlphaCrest Capital Management first reported a position in Elanco Animal Health in Q1 2020 and held it in 10 quarters.
  • AlphaCrest Capital Management's Elanco Animal Health position peaked at $2.58M in Q2 2022.
  • 404 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.